Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Zepbound works by activating hormone receptors in the body to reduce appetite and food intake
Read More »FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro
FDA Investigating Hospitalizations Linked to Counterfeit Ozempic
Novo Nordisk has said that it is working with the FDA to make consumers aware of the counterfeits
Read More »Oral Contraceptives May Protect Against Rheumatoid Arthritis
In contrast, use of menopausal hormone therapy may increase the risk for late-onset rheumatoid arthritis
Read More »Rate of Current Use of Any Tobacco Product Down in High Schoolers in 2023
Use of any tobacco product reported by 10.0 percent of U.S. middle and high school students in 2023
Read More »Time-Restricted Eating Effective for Weight Loss, Lowering HbA1c
TRE without calorie counting is effective and yields significant reduction in body weight at six months
Read More »More Than Half of U.S. Adults Use Internet to Look for Health, Medical Information
Adults aged 30 to 44 years have highest use of internet for communicating with doctor, doctor's office
Read More »Testosterone Efficacious for Correcting Anemia in Middle-Aged Men
Fewer men without anemia developed anemia with testosterone replacement therapy versus placebo
Read More »Dementia Incidence Increased With Termination of Metformin
Association largely independent of changes in hemoglobin A1c and insulin usage
Read More »Doctors’ Group Expands Definition of ‘Infertility’
Same-sex couples and single people are now included in a new definition of infertility released by a leading medical group
Read More »Exposure to PFAS Linked to Increased Rate of Thyroid Cancer
56 percent increased rate of thyroid cancer diagnosis seen per doubling of linear perfluorooctanesulfonic acid intensity
Read More »